Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Physicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme.

Budai M, Chapela P, Gróf P, Zimmer A, Wales ME, Wild JR, Klebovich I, Petrikovics I, Szilasi M.

J Liposome Res. 2009;19(2):163-8. doi: 10.1080/17482940902724044.

PMID:
19235545
2.

Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.

Petrikovics I, Hong K, Omburo G, Hu QZ, Pei L, McGuinn WD, Sylvester D, Tamulinas C, Papahadjopoulos D, Jaszberenyi JC, Way JL.

Toxicol Appl Pharmacol. 1999 Apr 1;156(1):56-63.

PMID:
10101099
3.

Characterization of liposomal vesicles encapsulating rhodanese for cyanide antagonism.

Petrikovics I, Budai M, Baskin SI, Rockwood GA, Childress J, Budai L, Gróf P, Klebovich I, Szilasi M.

Drug Deliv. 2009 Aug;16(6):312-9. doi: 10.1080/10717540903003711.

PMID:
19606945
4.

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism.

Petrikovics I, McGuinn WD, Sylvester D, Yuzapavik P, Jiang J, Way JL, Papahadjopoulos D, Hong K, Yin R, Cheng TC, DeFrank JJ.

Drug Deliv. 2000 Apr-Jun;7(2):83-9.

PMID:
10892408
5.

Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon.

Petrikovics I, Papahadjopoulos D, Hong K, Cheng TC, Baskin SI, Jiang J, Jaszberenyi JC, Logue BA, Szilasi M, McGuinn WD, Way JL.

Toxicol Sci. 2004 Feb;77(2):258-62. Epub 2003 Jul 11.

6.

Preparation and characterization of doxorubicin liposomes.

Niu G, Cogburn B, Hughes J.

Methods Mol Biol. 2010;624:211-9. doi: 10.1007/978-1-60761-609-2_14.

PMID:
20217598
7.

Structure-based and random mutagenesis approaches increase the organophosphate-degrading activity of a phosphotriesterase homologue from Deinococcus radiodurans.

Hawwa R, Larsen SD, Ratia K, Mesecar AD.

J Mol Biol. 2009 Oct 16;393(1):36-57. doi: 10.1016/j.jmb.2009.06.083. Epub 2009 Jul 22.

PMID:
19631223
8.

Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.

Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P.

Int J Pharm. 2006 Apr 7;312(1-2):53-60. Epub 2006 Feb 15.

PMID:
16469460
9.

Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations.

Budai L, Hajdú M, Budai M, Gróf P, Béni S, Noszál B, Klebovich I, Antal I.

Int J Pharm. 2007 Oct 1;343(1-2):34-40. Epub 2007 Apr 24.

PMID:
17537601
10.

Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.

Herkenhoff S, Szinicz L, Rastogi VK, Cheng TC, DeFrank JJ, Worek F.

Arch Toxicol. 2004 Jun;78(6):338-43. Epub 2004 Feb 19.

PMID:
14985944
11.

Liposomal gels for vaginal drug delivery.

Pavelić Z, Skalko-Basnet N, Schubert R.

Int J Pharm. 2001 May 21;219(1-2):139-49.

PMID:
11337174
12.

Characterization and stability of various liposome-encapsulated enoxacin formulations.

Fang JY, Lin HH, Hsu LR, Tsai YH.

Chem Pharm Bull (Tokyo). 1997 Sep;45(9):1504-9.

PMID:
9332003
13.

Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance.

Peleg-Shulman T, Gibson D, Cohen R, Abra R, Barenholz Y.

Biochim Biophys Acta. 2001 Feb 9;1510(1-2):278-91.

14.

Recent trends in drug delivery systems: liposomal drug delivery system--preparation and characterisation.

Chandran S, Roy A, Mishra B.

Indian J Exp Biol. 1997 Aug;35(8):801-9. Review.

PMID:
9475051
15.

Encapsulation of phosphotriesterase within murine erythrocytes.

Pei L, Omburo G, McGuinn WD, Petrikovics I, Dave K, Raushel FM, Wild JR, DeLoach JR, Way JL.

Toxicol Appl Pharmacol. 1994 Feb;124(2):296-301.

PMID:
8122276
16.

Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism.

Petrikovics I, Cheng TC, Papahadjopoulos D, Hong K, Yin R, DeFrank JJ, Jaing J, Song ZH, McGuinn WD, Sylvester D, Pei L, Madec J, Tamulinas C, Jaszberenyi JC, Barcza T, Way JL.

Toxicol Sci. 2000 Sep;57(1):16-21.

17.

Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase.

Pei L, Petrikovics I, Way JL.

Fundam Appl Toxicol. 1995 Dec;28(2):209-14.

PMID:
8835230
18.

Preparation and characterization of methoxy polyethylene glycol-conjugated phosphotriesterase as a potential catalytic bioscavenger against organophosphate poisoning.

Jun D, Musilová L, Link M, Loiodice M, Nachon F, Rochu D, Renault F, Masson P.

Chem Biol Interact. 2010 Sep 6;187(1-3):380-3. doi: 10.1016/j.cbi.2010.03.017. Epub 2010 Mar 15.

PMID:
20230809
19.

Enhanced stability of enzyme organophosphate hydrolase interfaced on the carbon nanotubes.

Pedrosa VA, Paliwal S, Balasubramanian S, Nepal D, Davis V, Wild J, Ramanculov E, Simonian A.

Colloids Surf B Biointerfaces. 2010 May 1;77(1):69-74. doi: 10.1016/j.colsurfb.2010.01.009. Epub 2010 Jan 21.

PMID:
20138483
20.

Effect of different preparation methods on physicochemical properties of salidroside liposomes.

Fan M, Xu S, Xia S, Zhang X.

J Agric Food Chem. 2007 Apr 18;55(8):3089-95. Epub 2007 Mar 21.

PMID:
17373810
Items per page

Supplemental Content

Write to the Help Desk